Adv. Amir Naiberg

CEO of Yeda R&D, Technology Transfer of the Weizmann Institute of Science

Commercialization of Know-How and IP Rights (TTOS) session

Amir Naiberg was appointed as CEO of Yeda in 2006. Yeda is ranked as one of the top three technology organizations in the world. Yeda's best known business partners include Teva, Merck Serono, BMS, Abbott, Baxter, Biolex, News Group, Xennex, Lilly (Imclone), as well as many start-up companies. Amir works closely with various branches of the Israeli administration including the Knesset. Amir serves on several BODs and is one of the founders of Israel Technology Transfer Organization.

Amir Naiberg holds a LL.M. degree from the University of Connecticut School of Law, a LL.B. degree from the Hebrew University of Jerusalem and is a graduate of the Israeli Executive Leadership Program - Merage Foundation. Prior to his appointment as Yeda's CEO, Amir served as Yeda's General Counsel for six years. Before joining Yeda, Mr. Naiberg worked for a private law firm specializing in intellectual property, privacy, and cyberspace law.